Front loaded medical fluid syringe mounting

ABSTRACT

Various sealing structures are used in a front-loading injector, for preventing leakage of spilled fluid from an external surface of a syringe into the vicinity of the drive ram. For example, a sealing gasket may be incorporated into the front face of the injector housing, for mating to the rearward circular edge of the cylindrical body of a syringe. Alternatively, sealing and locking functions may be performed by a single structure on the rearward end of the syringe. Further, leakage may be prevented by including a non-planar sealing flange on the syringe, positioned on the syringe forward of the locking structure, or by a two-piece structure, including a syringe and a separate leakage stopping washer for surrounding the syringe to halt the flow of fluid along the exterior of the syringe. (As part of this aspect, or as an independent feature, the syringe may include an annularly discontinuous flange forward of the locking structure, for providing mechanical support for the syringe against the injector.) Alternatively, an iris-like structure may be incorporated into the front surface of the injector, for closing about the syringe upon insertion of the syringe into the injector.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a division of U.S. patent application Ser. No.10/386,957 filed 12 Mar. 2003, now abandoned, which is a division ofU.S. Pat. No. 6,569,127, filed 20 Sep. 2000, which is a continuation ofnow abandoned U.S. patent application Ser. No. 08/896,695 filed 18 Jul.1997, the entire disclosure of which is hereby incorporated byreference.

Further, this application is related to co-pending U.S. patentapplication Ser. No. 11/458,463 filed 19 Jul. 2006; co-pending U.S.patent application Ser. No. 11/420,664 filed 26 May 2006; co-pendingU.S. patent application Ser. No. 11/677,946 filed 22 Feb. 2007, entitledAdaptor and Syringe for Front-Loading Medical Fluid Injector, andco-pending U.S. patent application Ser. No. 11/677,926, filed 22 Feb.2007, entitled Methods For Using A Front-Loading Medical Fluid Injector,which claims the same priority as above, the entire disclosure of eachof which is hereby incorporated by reference.

FIELD OF THE INVENTION

The present invention relates to medical fluid injectors for injectingmedical fluid into patients.

BACKGROUND OF THE INVENTION

Injectors are devices that expel fluid, such as contrast media, from asyringe and through a tube into an animal. An injector often includes aninjector unit, usually adjustably fixed to a stand or support, which hasa drive ram that couples to the plunger of a syringe to drive theplunger forward to expel fluid into the tube, or to drive the plungerrearward to draw fluid into the syringe to fill it. Usually the syringeis disposable.

U.S. Pat. No. 5,300,031, which is assigned to the same assignee as thisapplication, discloses a front-loading injector, and is incorporated byreference herein in its entirety. This injector has a pressure jacketmounted to its front face for receiving a syringe. A syringe having anopen back end is inserted into the pressure jacket, and an umbrellasurface on the front of the syringe, is coupled to the pressure jacketby a rotating motion. This same rotating motion causes the plunger inthe syringe to couple to the end of the ram. The pressure jacketsupports the side walls of the syringe against injection pressure duringoperation of the injector. After an injection, a reverse rotating motionunlocks the syringe from the pressure jacket and releases the plungerfrom the ram, so the syringe can be removed and replaced.

A second front-loading injector structure is disclosed in U.S. Pat. No.5,383,858, which is also incorporated by reference herein in itsentirety. This front loading injector structure is similar in manyrespects to that disclosed in U.S. Pat. No. 5,300,031, with the maindifference that the injector of the primary figures (FIGS. 1-8) of U.S.Pat. No. 5,383,858, does not include a pressure jacket on the frontsurface thereof. Rather, the syringe is made of a hard plastic materialwhich is deemed sufficiently self-supporting to withstand injectionpressures. In the front-loading injector of U.S. Pat. No. 5,383,858, thesyringe and injector, and the plunger and ram, are connected to eachother by a single twisting motion, and disconnected from each other by areverse twisting motion; thus, the connection and disconnectionprocedures are similar to that used by the injector of U.S. Pat. No.5,383,858.

Both of the above-noted U.S. Patents show syringes incorporating lockingstructures for locking the syringe to the front surface of the injector,as well as a disc-like, annular sealing flange for contacting andsealing to an annular edge on the front surface of the injector or itspressure jacket. This annular sealing flange prevents contrast media orany other injectable fluid which might flow along the outside of thesyringe, from leaking into the area where the ram exits the injector,and potentially fouling the mechanical systems inside of the injector.

SUMMARY OF THE INVENTION

There are several disadvantages to including an annular disc-likesealing flange on the syringe. This disc-like flange can be difficult tomold, and when molded to a sufficient thinness to permit a sealing,interference fit with the front face of the injector, can be fragile andsubject to breakage. Accordingly, there is a need for a front-loadinginjector and syringe which does not require the inclusion of a disc-likesealing flange on the syringe.

In accordance with a first aspect of the present invention, this need ismet by an injector including an annular, sealing gasket incorporatedinto the front face of the injector housing, for mating to the rearwardcircular edge of the cylindrical body of a syringe. A locking structureon the outer surface of the syringe and the face of the injector, holdsthe syringe in tight sealing contact with the gasket on the face of theinjector, preventing leakage from the outside surfaces of the syringeinto the vicinity of the drive mechanism of the injector.

In specific disclosed embodiments of this aspect of the invention, thelocking structure on the outer surface of the syringe comprises one ormore radially extending members, which mate to one or more radiallyextending members on the face of the injector. The members on the faceof the injector may be radially disposed tabs, for receiving flanges onan outer surface of the syringe. The flanges on the syringe are rotatedinto and out of engagement with the tabs on the face of the injector.The tabs on the injector may form a radially outwardly-facing groove,for receiving a radially inwardly-facing flange on the syringe, oralternatively, the tabs on the injector may have a radiallyinwardly-facing groove, for receiving a radially outwardly-facing flangeon the syringe.

In a second specific embodiment, the face of the injector may include aslot, for receiving the radially-outwardly extending members on thesyringe, by sliding the syringe transversely to its axis, intoengagement with the injector. As a third alternative, the face of theinjector may include a rotating turret, for engaging radially-outwardlyextending members on the syringe, and rotating the syringe transverselyrelative to its axis, into registration with the drive mechanism on theinjector.

In accordance with a second aspect of the present invention, the sealingfunction is provided by incorporating sealing and locking functions intoa single structure on the rearward end of the syringe. Specifically, theend of the syringe includes a radially outwardly-extending sealingstructure, which includes integral locking members for engaging matingstructures on the face of the injector.

In specific disclosed embodiments of this aspect, these locking membersform a channel in the sealing structure on the syringe, for receivingtabs on an interior surface of the injector housing, so that the sealingstructure may be inserted into the housing and rotated to lock thesyringe to the injector.

In accordance with another aspect of the present invention, leakage isprevented by including a non-planar sealing flange on the syringe,positioned on the syringe forward of the locking structure. In specificembodiments of this aspect, the non-planar sealing flange includes acusp feature for diverting fluid flowing along the surface of thesyringe.

In yet another aspect of the present invention, leakage is prevented bya two-piece structure, including a syringe and a separate leakagestopping washer for surrounding the syringe to halt the flow of fluidalong the exterior of the syringe.

A separate unique feature of this aspect of the invention, is thestructure of the syringe, which includes an annularly discontinuousflange forward of the locking structure, for providing mechanicalsupport for the syringe against the injector. This discontinuous flangenot only provides mechanical support for the syringe when mounted to theinjector, but also aids in positioning the leakage stopping washer,which when installed abuts against the annularly discontinuous flange.

In accordance with another aspect of the present invention, leakage isprevented by an iris-like structure on the front surface of theinjector. The iris-like structure includes mechanical actuators forclosing the iris-like structure about the syringe upon insertion of thesyringe into the injector, thus forming a seal between the syringe andinjector.

In specific embodiments of this aspect, the mechanical actuatorsinteract with locking flanges on the rearward surface of the syringe,for translating the iris-like structure into engagement of the syringeupon rotation of the locking flanges on the syringe into the mechanicalactuators.

The above and other objects and advantages of the present inventionshall be made apparent from the accompanying drawings and thedescription thereof.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute apart of this specification, illustrate embodiments of the invention and,together with a general description of the invention given above, andthe detailed description of the embodiments given below, serve toexplain the principles of the invention.

FIG. 1 is a perspective view of a first embodiment of a syringe and areplacement face plate for the injector described in U.S. Pat. No.5,383,858;

FIG. 2 is a cross-sectional view taken on line 2-2 of FIG. 1, of thesyringe and injector of FIG. 1 when coupled together;

FIG. 3 is a perspective view of a second embodiment of a syringe and areplacement face plate for the injector described in U.S. Pat. No.5,383,858;

FIG. 4 is a perspective view of a third embodiment of a syringe and areplacement face plate for the injector described in U.S. Pat. No.5,383,858;

FIG. 5 is a perspective view of a fourth embodiment of a syringe andreplacement face plate for the injector described in U.S. Pat. No.5,383,858;

FIG. 6 is a perspective view of a fifth embodiment of a replacementsyringe for the injector described in U.S. Pat. No. 5,383,858;

FIG. 7 is a perspective view of a sixth embodiment of a replacementsyringe for the injector described in U.S. Pat. No. 5,383,858;

FIG. 8 is partial cut-away front view of a seventh embodiment of areplacement face plate for the injector described in U.S. Pat. No.5,383,858, showing a sealing mechanism in an open position for receivinga syringe;

FIG. 9 is a view similar to FIG. 8, showing the sealing mechanism in aclosed position as a result of a syringe being mounted thereto;

FIG. 10 is a cross-sectional view taken on line 10-10 of FIG. 8, of theactuating mechanism incorporated in the face plate of FIGS. 8 and 9;

FIG. 11 is a partial cut-away front view of an eighth embodiment of areplacement face plate for the injector described in U.S. Pat. No.5,383,858, showing a sealing mechanism in an open position for receivinga syringe;

FIG. 12 is a view similar to FIG. 11, showing the sealing mechanism in aclosed position as a result of a syringe being mounted thereto.

DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS

Referring now to FIG. 1, in accordance with a first embodiment of thepresent invention, the injector disclosed in U.S. Pat. No. 5,383,858 isoutfitted with a replacement face plate 10, incorporating features formounting a syringe 12. Face plate 10 includes an opening 11 at a centrallocation thereof. The syringe drive ram 13 of the injector extendsthrough opening 11 to engage the plunger of a syringe mounted to faceplate 10, by a relative rotational motion of the plunger and ram, in themanner described in U.S. Pat. No. 5,383,858. Surrounding opening 11 is acircular gasket 15 of a flexible material such as rubber.

The structure of syringe 12 is notable in that it does not include adisc-like sealing flange on its exterior. Rather, the exterior surfaceof cylindrical barrel 14 of the syringe is smooth but for two lockingflanges 16 a and 16 b extending from the rearward end of the syringe.The syringe also includes, as is conventional, a plunger 19 sealinglyengaging an interior of cylindrical barrel 14 and sliding within barrel14 between an open rearward end of barrel 14 and a closed forward end18. Forward end 18 terminates in a discharge extension 20, to whichtubing is mounted to carry injected fluid to a patient. A rearwardsurface of plunger 19 includes flanges 21 a and 21 b similar to thosedescribed in U.S. Pat. No. 5,383,858, for engaging head 17 of plungerdrive ram 13.

Flanges 16 a and 16 b on syringe 12 are matable to locking structures 22a and 22 b, respectively, on the front face of face plate 10.Specifically, face plate 10 includes radially outwardly-extending tabs24 a and 24 b, which form radially outwardly-facing grooves 26 a and 26b which extend partially annularly about opening 11 in face plate 10.Locking flanges 16 a and 16 b on the rearward end of syringe 12, includeradially inwardly-extending tabs 28 a and 28 b positioned to interlockinto grooves 26 a and 26 b behind tabs 24 a and 24 b.

Referring now to FIGS. 1 and 2, in this embodiment, a syringe isinstalled onto injector by first translating the syringe along its axisin the orientation shown in FIG. 1, until the rearward circular edge 30of cylindrical barrel 14 of the syringe, engages gasket 15 surroundingopening 11 in face plate 10. Then, syringe 12 is rotated clockwise toguide tabs 28 a and 28 b on the rearward end of syringe 12 into grooves26 a and 26 b on face plate 10. When syringe 12 is rotated ninetydegrees clockwise, tab 28 a engages stop 32 a at the end of groove 26 a,thus preventing further clockwise rotation of syringe 12. (Another stop32 b, is incorporated at the clockwise end of groove 26 b.) Thus, wheninstalling a syringe, the syringe is rotated clockwise for approximatelyninety degrees until further rotation is impossible, at which point theuser can be certain that the syringe is fully installed.

To facilitate installation of a syringe to face plate 10, the diameterof locking structures 22 a and 22 b may be slightly reduced at theircounter-clockwise ends, to facilitate mating of the syringe lockingstructures 16 a and 16 b to flanges 22 a and 22 b on face plate 10. Inaddition, the thickness of tabs 24 a and 24 b may be reduced at theircounter-clockwise ends (e.g., to the thickness shown in hidden lines at31 a and 31 b), to facilitate mating of the syringe locking structuresto tabs 24 a and 24 b and to tighten the rearward circular edge 30 ofsyringe 12 against gasket 15 as the syringe is rotated clockwise intoposition. Furthermore, small buttons and detents, or other features, maybe incorporated into locking structures 16 a and 16 b and/or flanges 22a and 22 b, placed so as to interact and provide audible and/or tactilefeedback to a user installing a syringe onto face plate 10, so the userknows when the syringe is properly positioned.

As is visible in FIG. 2 in particular, ninety-degree rotation of syringe12 into engagement with face plate 10, also causes flanges 21 a and 21 bon plunger 19 to engage head 17 on plunger drive ram 13, so that plungerdrive ram 13 can thereafter drive plunger 19 forward and rearward withinthe cylindrical barrel 14 of the syringe, to perform an injection.

Also visible in FIG. 2, is the interaction of the rearward surface 30 ofsyringe 12, and gasket 15. When syringe 12 is fully installed to faceplate 10, gasket 15 is partially compressed against rearward surface 30of syringe 12, so as to form a seal therewith. This seal reduces leakageof injection fluid from the exterior surface of the barrel 14 of syringe12, into the area where drive ram 13 exits from face plate 10. Thisgasket provides the functions provided by the disc-shaped sealing flangedescribed in the above-noted U.S. Patents, without requiring complexmanufacturing or involving breakable parts.

It will be appreciated that alternative forms of locking structure maybe used to mount syringe 12 to face plate 10. For example, tabs 24 a, 24b on the face plate 10 may form an inwardly-facing groove such as thegroove (23 s) shown in the main figures (FIGS. 1-8) of U.S. Pat. No.5,383,858 in particular, for mounting to outwardly-projecting structureson syringe 12. In one specific embodiment, the outwardly-projectinglocking structures 16 a and 16 b on the rearward end of syringe 12 aresized so as to be insertable into the inwardly-facing groove 23 s of theinjector described in U.S. Pat. No. 5,383,858, so that syringe 12 may bemounted without modification to the injector of U.S. Pat. No. 5,383,858,or may be mounted to the substitute face plate 10 shown in FIGS. 1 and2.

Referring now to FIG. 3, a third alternative locking structure can bedescribed. In this alternative, a replacement face plate 33 includesradially inwardly-extending tabs 34 which form an inwardly-facing slot36 for gripping locking structure on the rearward end of the syringe 12.In this embodiment, syringe 35 may be mounted by sliding the syringetransversely to its axis, into slot 36 and engagement with tabs 34. Thelocking structure on the rearward end of syringe 35 may include a numberof tabs such as are shown in FIGS. 1 and 2, or may be a continuous,annular flange 38 such as is shown in FIG. 3.

It will be appreciated that the face plate 33 shown in FIG. 3 includes agasket 15 identical in function and placement to the gasket 15 discussedabove with reference to FIGS. 1 and 2. Gasket 15 forms a seal with therearward surface of syringe 35, to form a seal therewith to inhibit theflow of fluid from the exterior of syringe 35 into the regionsurrounding plunger drive ram 13.

In the embodiment of FIG. 3, flanges 21 a and 21 b on plunger 19 aresimilar to those described above and in U.S. Pat. No. 5,383,858, and arecoupled to head 17 of plunger drive ram 13 by rotating syringe 12 aftersyringe 12 has been fully inserted into slot 36 on face plate 33. Othercoupling structures could also be used, including, for example, adisk-shaped end on drive ram 13, for engaging flanges 21 a and 21 b uponlateral translation of syringe 35 into slot 36 on face plate 33, withoutrequiring rotation.

It will be appreciated that keyed features might be included into slot36 and/or flange 38 to require that syringe 35 be placed in a properrotational orientation before syringe 35 can be slid into slot 36. Forexample, the opening of slot 36 may be slightly narrower than the widestdiameter of flange 38, and flange 38 might include a flat which must beoriented properly for flange 38 to pass through the narrowed opening ofslot 36 and into a mounted position.

Referring now to FIG. 4, a second alternative structure for mounting asyringe to an injector is shown. In this alternative, face plate 39incorporates a turret 40. Turret 40 includes two jaws 42 a and 42 b intowhich one or two syringes can be inserted. The syringe 41 is similar tothe syringe shown in FIG. 3, in that it includes a continuous, annularflange 43 at its rearward end. As before, a gasket (not shown) isincorporated into face plate 39, surrounding the opening through whichthe plunger drive ram emerges from the injector, so that the rearwardsurface of syringe 41 forms a seal therewith to inhibit leakage ofspilled fluid into the internal mechanisms of the injector.

Referring now to FIG. 5, a second type of syringe-injector sealingstructure can be discussed. The injector has a replacement face plate48, for mounting a syringe 50. Syringe 50 includes a single-piece,combination locking and sealing structure 54 at its rearward end.Structure 54, which has a conically-shaped outer surface, has twochannels 56 a and 56 b molded therein. Each channel 56 a and 56 bincludes an axial opening portion (57 a in channel 56 a, not shown inchannel 56 b) and an annular portion (59 a in channel 56 a, 59 b inchannel 56 b). Face plate 48 includes a conically-shaped opening 58surrounding injector drive ram 13, which is matable to theconically-shaped outer surface of structure 54 on the rearward end ofsyringe 50. Within opening 58 are tabs 60 positioned annularly about aninterior of opening 58 and sized to fit into the axial opening portionsof channels 56 a and 56 b of syringe structure 54. A gasket (not shown)may also be incorporated into the rim of opening 58 forward of tabs 60for sealing purposes.

Syringe 50 is installed into injector face plate 48 by insertingstructure 54 at the rearward end of syringe 50 into opening 58, withtabs 60 aligned with the axial opening portions of channels 56 a and 56b, and then rotating syringe 50 clockwise over an angle of approximatelyninety degrees, thus locking tabs 60 into the annular portions 59 a and59 b of channels 56 a and 56 b. Once locked to face plate 48, a seal isformed between syringe 50 and face plate 48 which inhibits flow ofspilled fluid from the exterior of syringe 50 into the mechanism ofdrive ram 13.

Referring now to FIG. 6, in accordance with a further embodiment of thepresent invention, a syringe such as that shown in U.S. Pat. No.5,383,858 can be improved by enhancing the rigidity of the sealingflange. Specifically, the sealing flange can be made non-planar, e.g.,as shown in FIG. 6, the sealing flange 64 may be formed with acusp-shaped feature 66, thus enhancing the rigidity of the flange whilecontinuing to guide spilled fluid flowing rearwardly along the exteriorof the syringe away from the drive mechanism. The non-planar sealingflange shown in FIG. 6 thus provides the leakage protection function ofthe planar flange shown in U.S. Pat. No. 5,383,858. U.S. Pat. No.5,383,858 further indicates that the sealing flange described in thatpatent stabilizes the syringe while mounted to the injector. Thisfunction is also provided by the sealing flange 62 shown in FIG. 6 inthat there are substantial annular portions of sealing flange 62 whichcontact the sealing rim on the injector shown in U.S. Pat. No.5,383,858, lending the needed stability.

Referring now to FIG. 7, in accordance with a further embodiment, asyringe 68 for mounting to the injector described in U.S. Pat. No.5,383,858, includes an annular sealing flange which is annularlydiscontinuous, i.e., separated into segments such as 70. An annularlydiscontinuous flange, while not necessarily accomplishing the sealingfunction described in U.S. Pat. No. 5,383,858, does provide stabilityfor the mounted syringe, in that segments 70 contact and form aninterference fit with the face of the injector. (The placement ofsegment 70, and additional segments 72, can be determined based on thestability needed.) Furthermore, the annularly discontinuous segments 70,can perhaps be made of more thick layers of plastic, since the gapsbetween the segments make the segments more able to flex than anannularly continuous flange. Moreover, an annular flange formed insegments may be more easily molded than an annularly continuous flange.

To provide a sealing function, particularly in connection with syringeshaving an annularly discontinuous sealing flange, but also in otherapplications, a leakage stopping washer 74 may be provided inconjunction with the syringe. Washer 74 may be formed of solid rubber,sponge rubber, paper or any other absorbent and/or sealing material.Washer 74 may be disposable, and sold with syringe 68 for one-time use,or may be reusable. In either case, washer 74 is slipped over thecylindrical barrel 76 of syringe 68. Washer 74 is made of an elasticmaterial and is formed with a slight interference fit relative to thecylindrical barrel 76 of syringe 68, so that washer 74 forms a seal withbarrel 76 to inhibit leakage past washer 74. In one embodiment, flangesegments 70 are used to position washer 74 at the rearward end ofsyringe 68 so that washer 74 is opposite to the face of the injectorwhen syringe 68 is installed on the injector. In other embodiments,washer 74 may be positioned at any other location along the cylindricalbarrel 76 of syringe 68.

Referring to FIG. 8, in accordance with a further embodiment, a sealingfunction may be provided by an iris-like structure on a face plate ofthe injector, for closing about the syringe to provide a seal betweenthe face plate and outer barrel of the syringe. As seen in FIG. 8, thesyringe 78 includes a cylindrical barrel 80, and locking flanges 82projecting from barrel 80 adjacent a rearward end of the syringe. Thus,the structure of the syringe is similar to that of the syringe shown inU.S. Pat. No. 5,383,858, with the annular sealing flange removed.

The syringe 78 is mounted into an opening in a replacement face plate 86mounted on the front face of the injector. An opening 88 in the faceplate permits the plunger drive ram 13, and in particular theplunger-mounting head 17 thereof, to emerge from the injector and engageand drive the plunger within the syringe. Face plate 86 further includesannular grooves of the kind illustrated in U.S. Pat. No. 5,383,858, sothat locking flanges 82 of a syringe may be inserted into the face plate86 in the orientation shown in FIG. 8, and then rotated into a lockedposition on the face plate.

As seen in FIG. 8, in addition to the structures described above, faceplate 86 includes two sealing arms 90 a and 90 b which, in the openposition illustrated in FIG. 8, permit locking flanges 82 of a syringeto pass into the face plate for locking to the face plate. Sealing arms90 a and 90 b are arcuate sections, having an inside radius of curvaturealong edges 92 a and 92 b which is approximately equal to the radius ofthe cylindrical wall 80 of the syringe 78.

Referring now to FIGS. 8 and 9, the motion of sealing arms 90 a and 90 bfrom their open position of FIG. 8 to their closed position of FIG. 9can be illustrated. Specifically, when a syringe is inserted into faceplate 86 in the orientation shown in FIG. 8, and then turned clockwiseto the orientation shown in FIG. 9, this rotational motion causessealing arms 90 a and 90 b to similarly rotate clockwise from the openpositions shown in FIG. 8 into the closed positions shown in FIG. 9. Ascan be seen in FIG. 9, in their closed positions the interior edges 92 aand 92 b of sealing arms 90 a and 90 b engage the outer cylindrical wall80 of the syringe and form a seal therewith, thus inhibiting leakage ofspilled fluid along the wall of the syringe. (The interior edges 92 aand 92 b of sealing arms 90 a and 90 b may carry rubber or otherflexible seals such as are shown at edges 92 a and 92 b illustrated inFIG. 10.) At the same time sealing arms 90 a and 90 b lend mechanicalstability to the syringe when it is mounted on the injector face plate86.

Now referring to FIGS. 8, 9 and 10, in the illustrated embodiment,rotation of arms 90 a and 90 b is generated through mechanicalmechanisms including a lever arm 94, which drives a pinion gear 96,which meshes with a main gear 98 rotationally coupled to the sealing arm90. Clockwise rotation of the syringe from the position shown in FIG. 8to the position shown in FIG. 9, causes locking flange 82 of the syringeto engage and rotate lever arm 94 counterclockwise. Counterclockwisemotion of lever arm 94 causes counterclockwise motion of pinion gear 96.Pinion gear 96, meshing with main gear 98, causes main gear 98 to rotateclockwise, driving the connected sealing arm to rotate clockwise to itsclosed position.

As shown in FIG. 10, main gear 98 is rotationally locked to a shaft 100,which passes through face plate 86 and into sealing arm. Thus, rotationof main gear 98 causes rotation of shaft 100 and corresponding rotationof sealing arm 90 b. A torsion spring 102 coupled between main gear 98and face plate 86 produces a return force tending to rotate main gear98, shaft 100 and sealing arm 90 counterclockwise to an open positionwhenever the syringe is rotated counterclockwise toward its disengagedposition.

Referring to FIGS. 11 and 12, in an alternative embodiment, sealing arms101 a and 101 b translate laterally between their open and closedpositions, to provide a sealing function when a syringe is installed tothe injector. The syringe used in this embodiment is similar to thatused in the embodiment of FIGS. 8, 9 and 10. However, sealing arms 101 aand 101 b are different in structure. Sealing arms 101 a and 101 binclude, on their rearward faces, channels 103 a and 103 b, forreceiving pins 104 a and 104 b on the face plate 105 of the injector.Sealing arms 101 a and 101 b translate laterally with respect to theaxis of the syringe, such that pins 104 a and 104 b slide withinchannels 103 a and 103 b, guiding the motion of arms 101 a and 101 b.Motion is imparted to sealing arms 101 a and 101 b by lever arms 106 aand 106 b, respectively, which pivot about axes 107 a and 107 b,respectively. Lever arms 106 a and 106 b include pins 110 a and 110 b attheir exterior ends, which are received into channels 108 a and 108 b onthe rearward faces of sealing arms 101 a and 101 b. Counterclockwiserotation of lever arms 106 a and 106 b causes pins 110 a and 100 b tointeract with channels 108 a and 108 b to drive sealing arms 101 a and101 b to the closed positions shown in FIG. 12. Clockwise rotation oflever arms 106 a and 106 b causes pins 110 a and 100 b to interact withchannels 108 a and 108 b to drive sealing arms 101 a and 101 b to theopen positions shown in FIG. 11.

Insertion and rotation of a syringe into a locked position in face plate105, causes rotation of lever arms 106 a and 106 b to close sealing arms101 a and 101 b. Specifically, a syringe is inserted with lockingflanges 82 in the positions shown in FIG. 11. Next, the syringe barrel80 is rotated clockwise approximately ninety degrees, from theorientation shown in FIG. 11 to the orientation shown in FIG. 12. Thisrotation causes locking flanges 82 to engage ends 112 a and 112 b ofsealing arms 101 a and 101 b, causing counterclockwise rotation oflevers 106 a and 106 b about axes 107 a and 107 b, thus bringing sealingarms 101 a and 101 b to their closed positions shown in FIG. 12.

Counterclockwise rotation of the syringe to unlock it from face plate105, opens sealing arms 101 a and 101 b to permit the syringe to beremoved. Specifically, torsion springs such as 114 a and 114 b on eachlever 106 a and 106 b, exert a force upon levers 106 a and 106 b to urgelevers 106 a and 106 b to rotate clockwise. Thus, when the syringe isrotated so that locking flanges 82 no longer interact with ends 112 aand 112 b of levers 106 a and 106 b, levers 106 a and 106 b rotateclockwise, opening sealing arms 101 a and 101 b to the positions shownin FIG. 11, so that the syringe may be removed.

While the present invention has been illustrated by a description ofvarious embodiments and while these embodiments have been described inconsiderable detail, it is not the intention of the applicants torestrict or in any way limit the scope of the appended claims to suchdetail. Additional advantages and modifications will readily appear tothose skilled in the art. The invention in its broader aspects istherefore not limited to the specific details, representative apparatusand method, and illustrative example shown and described. Accordingly,departures may be made from such details without departing from thespirit or scope of applicant's general inventive concept.

What is claimed is:
 1. A syringe for a front-loading medical fluidinjector, the syringe comprising: a body having an interior wall, aclosed forward end with a discharge opening therein, and an openrearward end; a plunger mounted within the body in sealing contact withthe interior wall of the body; and a structure extending radiallyoutward from and integrally included in the body, comprising a forwardstructure closer to the forward end of the body and a rearward structurecloser to the rearward end of the body, the forward structure extendingradially outward from the body at its furthest radially outward extent adistance greater than the radially outward extension of the rearwardstructure at its furthest radially outward extent, the rearwardstructure tapering inwardly proceeding in a direction of the rearwardend of the body, wherein the forward structure and the rearwardstructure are aligned with each other in a length dimension of thesyringe and are separated by a channel to receive a tab on an medicalfluid injector when the syringe is installed on the medical fluidinjector, and wherein the channel comprises a closed end that extendsbetween the forward and rearward structures.
 2. The syringe of claim 1wherein the forward structure tapers inwardly proceeding in thedirection of the rearward end of the body.
 3. The syringe of claim 1wherein the structure is a sealing structure for forming a seal with aninjector.
 4. The syringe of claim 1 wherein the structure is a lockingstructure for forming a locking engagement with an injector.
 5. Thesyringe of claim 1 further comprising fluid, for use in an imagingprocedure, within the body between the plunger and the closed forwardend.
 6. The syringe of claim 1 further comprising contrast media withinthe body between the plunger and the closed forward end.
 7. The syringeof claim 1 wherein the body is cylindrical.
 8. The syringe of claim 1wherein the structure extends substantially to the rearward end of thebody.
 9. The syringe of claim 1 wherein at least a portion of thestructure continuously declines in radius for the entire axial length ofthe structure.
 10. The syringe of claim 1, wherein the exterior of thebody is devoid of a disc-like, annular sealing flange designed tocontact and form a seal with an annular edge of a face plate of aninjector.
 11. The syringe of claim 1 wherein the rearward structure hasan axial opening defined therein.
 12. The syringe of claim 1 wherein therearward structure tapers substantially to the rearward end of the body.13. The syringe of claim 1 wherein the structure is located at therearward end of the body.
 14. The syringe of claim 1 wherein therearward structure is annularly discontinuous at at least one locationthereof.
 15. A syringe for a front-loading medical fluid injector, thesyringe comprising: a syringe barrel that is disposed about a referenceaxis that defines an axial dimension; a discharge opening; an open,rearward end; a plunger slidably disposed within said syringe barrel insealing contact with an interior of said syringe barrel; and a structureextending radially outwardly beyond said syringe barrel and comprising:a conically-shaped outer surface that extends inwardly toward saidreference axis proceeding in a direction of said open, rearward end; achannel that extends in a direction that is about said reference axis; aforward structure defining one side of said channel; and a rearwardstructure defining an opposite side of said channel and aligned with andspaced from said forward structure in said axial dimension, wherein afurthest radially outward extent of said forward structure is greaterthan a furthest radially outward extent of said rearward structure,wherein said conically-shaped outer surface comprises an outer surfaceof said forward structure as well as an outer surface of said rearwardstructure, and wherein a tab on a medical fluid injector is disposedwithin said channel so as to be disposed between said forward structureand said rearward structure when said syringe is installed on themedical fluid injector.
 16. The syringe of claim 15, wherein saidsyringe barrel is cylindrical.
 17. The syringe of claim 15, wherein saiddischarge opening and said open, rearward end are oppositely disposed.18. The syringe of claim 15, wherein said structure is a combinationlocking and sealing structure.
 19. The syringe of claim 15, wherein saidstructure is of a single-piece construction.
 20. The syringe of claim15, wherein said structure is disposed at said open, rearward end ofsaid syringe.
 21. The syringe of claim 15, wherein said forwardstructure is disposed closer to said discharge opening than saidrearward structure.
 22. The syringe of claim 15, wherein said forwardstructure and said rearward structure are positioned along a common axisthat is parallel with said reference axis.
 23. The syringe of claim 15,wherein said channel is oriented such that rotating said syringe aboutsaid reference axis directs a tab of a medical fluid injector into saidchannel when installing said syringe on the medical fluid injector. 24.The syringe of claim 15, wherein said channel does not extend completelyabout said reference axis.
 25. The syringe of claim 15, wherein saidchannel comprises a closed end that extends between said forward andrearward structures.
 26. The syringe of claim 25, wherein said closedend is encountered proceeding about said reference axis.
 27. The syringeof claim 15, further comprising a first said channel and a second saidchannel that are spaced about said reference axis.
 28. The syringe ofclaim 15, further comprising a second channel that extends from a rearend of said structure, and then in a direction of said dischargeopening, wherein said channel extends from said second channel.
 29. Thesyringe of claim 28, wherein said second channel is oriented such that atab of the medical fluid injector is directed into and along said secondchannel when moving said syringe in a first direction to position saidstructure within an opening on a medical fluid injector, and whereinsaid channel is oriented such that rotating said syringe in a seconddirection, different than said first direction, directs the tab of themedical fluid injector into and along said channel.